504914 Sigma-AldrichCNQX - CAS 115066-14-3 - Calbiochem
Sinónimos: 6-Cyano-7-nitroquinoxaline-2,3-dione, 6-Cyano-2,3-dihydroxy-7-nitro-quinoxaline
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
115066-14-3 | C₉H₄N₄O₄ |
Products
Número de referencia | Embalaje | Cant./Env. | |
---|---|---|---|
5049140001 | Frasco de vidrio | 10 mg |
Product Information | |
---|---|
CAS number | 115066-14-3 |
Form | Off-white to yellow solid |
Hill Formula | C₉H₄N₄O₄ |
Chemical formula | C₉H₄N₄O₄ |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | AMPA |
Primary Target K<sub>i</sub> | 0.6 – 2.11 →M for GluA1 – 4 and Ki |
Secondary target | Kainate |
Purity | ≥98% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
5049140001 | 04055977263688 |
Documentation
CNQX - CAS 115066-14-3 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
CNQX - CAS 115066-14-3 - Calbiochem Certificados de análisis
Cargo | Número de lote |
---|---|
504914 |
Referencias bibliográficas
Visión general referencias |
---|
Lee, S., et al. 2010. J. Neurophysiol. 103, 1728. King, A., et al. 1992. Br. J. Pharmacol. 107, 375. Long, S. et al. 1990. Br. J. Pharmacol. 100, 850.Harris, K., et al. 1989. Brain Res. 5, 185Honore, T., et al. 1988. Science. 241, 701.Birch, P., et al. 1988. Eur. J. Pharmacol. 156, 177. |